Oklahoma legislation · 2026 Regular Session
Oklahoma SB2074: Pharmacy benefit managers; prohibiting PBM from refusing to accept documentation; requiring information to be included in appeal. Effective date.
Status: Vetoed, April 22, 2026
What the bill says
An Act relating to pharmacy benefits managers; amending 59 O.S. 2021, Sections 357, as last amended by Section 2, Chapter 414, O.S.L. 2025, and 360, as last amended by Section 8, Chapter 300, O.S.L. 2025 (59 O.S. Supp. 2025, Sections 357 and 360), which relate to definitions and pharmacy benefits manager contractual duties to provider; defining term; prohibiting certain pharmacy benefits manager from refusing to accept certain documentation; requiring certain adjusted reimbursement amount if certain appeal is approved; allowing certain provider to request certain reversal or rebilling…
From the enrolled text, April 16, 2026:
An Act relating to pharmacy benefits managers; amending 59 O.S. 2021, Sections 357, as last amended by Section 2, Chapter 414, O.S.L. 2025, and 360, as last amended by Section 8, Chapter 300, O.S.L. 2025 (59 O.S. Supp. 2025, Sections 357 and 360), which relate to definitions and pharmacy benefits manager contractual duties to provider; defining term; prohibiting certain pharmacy benefits manager from refusing to accept certain documentation; requiring certain adjusted reimbursement amount if certain appeal is approved; allowing certain provider to request certain reversal or rebilling; requiring certain information to be included in certain appeal; requiring certain adjustments to include certain claim-level details within certain time period; prohibiting certain reimbursement amounts; updating statutory references; updating statutory language; and providing an effective date. SUBJECT: Pharmacy benefits managers SECTION 1. AMENDATORY 59 O.S. 2021, Section 357, as last amended by Section 2, Chapter 414, O.S.L. 2025 (59 O.S. Supp. 2025, Section 357), is amended to read as follows: Section 357. A. As used in Sections 357 through 360 360.1 of this title: 1. "Acquisition cost" means the total amount paid by a provider to acquire a drug, medical product, or device at the time of purchase as evidenced by verifiable purchase documentation such as an invoice or electronic price file. Acquisition cost shall include purchase price, procurement fees, and associated shipping …